These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8936720)

  • 41. Piracetam therapy for Down syndrome: a rush to judgment?
    Black SL
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176; author reply 1177-8. PubMed ID: 11576019
    [No Abstract]   [Full Text] [Related]  

  • 42. Piracetam for Sialorrhea in 2 Children With Intellectual Disability.
    Bozkurt H
    J Clin Psychopharmacol; 2015 Oct; 35(5):621-2. PubMed ID: 26252441
    [No Abstract]   [Full Text] [Related]  

  • 43. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 44. Piracetam study: poorly designed and misinterpreted.
    Croom J
    Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1176-8. PubMed ID: 11576020
    [No Abstract]   [Full Text] [Related]  

  • 45. Antimyoclonic efficacy of piracetam in idiopathic generalized epilepsy.
    Khani YA; Andermann F; Andermann E
    Epilepsia; 2005 Jul; 46(7):1145-6. PubMed ID: 16026569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective estimate of the nursing cost of autonomy impairment and cost benefit in clinical trials: feasibility and application of piracetam in demented elderly patients.
    Vlietinck R; Van Loon H; Van de Broele H; Tormans G
    Adv Ther; 1993; 10(5):226-44. PubMed ID: 10172000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Piracetam therapy does not enhance cognitive functioning in children with down syndrome.
    Lobaugh NJ; Karaskov V; Rombough V; Rovet J; Bryson S; Greenbaum R; Haslam RH; Koren G
    Arch Pediatr Adolesc Med; 2001 Apr; 155(4):442-8. PubMed ID: 11296070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
    Kyomen HH; Whitfield TH; Baldessarini RJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
    [No Abstract]   [Full Text] [Related]  

  • 49. [Efficacy of piracetam in vertigo].
    Mantsev EI; Sigaleva EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):90-4. PubMed ID: 19908411
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurology "with the bark off": tacrine, nursing home residents, and health services research.
    Phillips CD; Knopman DS
    Neurology; 1999 Jan; 52(2):227-30. PubMed ID: 9932935
    [No Abstract]   [Full Text] [Related]  

  • 51. [Atomoxetine and piracetam in the treatment of attention deficit hyperactivity disorder in children].
    Zavadenko NN; Suvorinova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):43-7. PubMed ID: 18833117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of neurotropic and stress-protective properties of piracetam and the derivative pyrido]1,2-a]pyrimidine].
    Kozlovskaia MM; Inozemtsev AN; Nikitin SV; Gochmuradov AG; Iakushev RA; Chabak-Gorbach R
    Biull Eksp Biol Med; 1995 Mar; 119(3):299-301. PubMed ID: 7795202
    [No Abstract]   [Full Text] [Related]  

  • 53. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Piracetam treatment in patients with cognitive impairment.
    Rao MG; Holla B; Varambally S; Raveendranathan D; Venkatasubramanian G; Gangadhar BN
    Gen Hosp Psychiatry; 2013; 35(4):451.e5-6. PubMed ID: 22763000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Convulsive effects of tacrine.
    Lebert F; Hasenbroekx C; Pasquier F; Petit H
    Lancet; 1996 May; 347(9011):1339-40. PubMed ID: 8622541
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug therapy of Alzheimer's disease. Problems of the criteria of clinical trials of nootropic drugs].
    Hirai S
    Nihon Rinsho; 1988 Jul; 46(7):1592-9. PubMed ID: 3221466
    [No Abstract]   [Full Text] [Related]  

  • 57. Advances in the treatment of Alzheimer's disease.
    Schneider LS
    Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
    [No Abstract]   [Full Text] [Related]  

  • 58. Concern about Piracetam treatment for children with Down syndrome.
    Holmes LB
    Pediatrics; 1999 May; 103(5 Pt 1):1078-9. PubMed ID: 10357649
    [No Abstract]   [Full Text] [Related]  

  • 59. Alzheimer's disease.
    Kennedy-Malone LM; Fletcher K
    Lippincotts Prim Care Pract; 1999; 3(2):163-8. PubMed ID: 10426059
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the dose-effect relationship in the therapy with piracetam (author's transl)].
    Kretschmar JH; Kretschmar CH
    Arzneimittelforschung; 1976; 26(6):1158-9. PubMed ID: 786310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.